Skip to main content

Table 1 Patient demographics and disease characteristics

From: Expression and clinical significance of PD-L1 and BRAF expression in nasopharyngeal carcinoma

Characteristic

 

N = 154

Cases

Percentage (%)

Age (Years)

 

Median

60

 

Range

26–83

 

< 60

71

46.1

≥60

83

53.9

Sex

 

Male

116

75.2

Female

38

24.8

Stage

 

I–II

67

43.5

III–IV

86

56.5

Treatment

 

Chemoradiation

124

80.5

Radiation Only

31

19.5

ECOG

 

0–1

131

85.0

≥2

24

15.0

Progression

 

Yes

76

49.4

No

78

50.6

PD-L1

 

0%

17

11.0

1–5%

22

14.3

5–49%

73

47.4

≥50

40

26.0

Unknown

2

1.3

BRAF V600E

 

Negative

139

90.3

Positive

13

8.4

Unknown

2

1.3

EGFR 19del

 

Negative

149

96.8

Positive

3

1.9

Unknown

2

1.3

EGFR L858R

 

Negative

151

98.1

Positive

0

0.0

Unknown

3

1.9

  1. Values are presented as number (%) unless otherwise stated
  2. Percentages may not sum to exactly 100 due to rounding
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us